STADA Arzneimittel AG Logo

STADA Arzneimittel AG

Pharmaceutical firm with generics, consumer healthcare, and specialty products.

SAZ | HM

Overview

Corporate Details

ISIN(s):
DE0007251803 (+1 more)
LEI:
529900FMTTLMH0P0DL10
Country:
Germany
Address:
Stadastraße 2 - 18, 61118 Bad Vilbel

Description

STADA Arzneimittel AG is a pharmaceutical company that operates on a three-pillar strategy consisting of generics, consumer healthcare products, and specialty pharmaceuticals. The company is a leading manufacturer of affordable generic medicines, which have been a core part of its business since its founding. In the consumer healthcare segment, STADA markets a wide portfolio of over-the-counter (OTC) products and well-known brands. The specialty pharmaceuticals division focuses on developing and marketing value-added medicines, including an expanding portfolio of biosimilars for therapeutic areas such as oncology, immunology, and bone health.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-20 00:00
Datum:20.08.2025
German 9.6 KB
2025-08-11 00:00
Datum:11.08.2025
German 2.2 MB
2025-07-07 00:00
§§ 264 Abs. 3, 264b HGB zum Geschäftsjahr vom 01.01.2024 bis zum 31.12.2024
German 5.6 KB
2025-02-04 00:00
Jahresabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
German 564.0 KB
2025-01-21 00:00
Konzernabschluss zum Geschäftsjahr vom 01.01.2023 bis zum 31.12.2023
German 1.8 MB
2024-02-14 00:00
Jahresabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
German 536.7 KB
2024-01-10 00:00
Konzernabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
German 1.5 MB
2023-02-23 14:15 English 3.9 KB
2023-02-23 11:25 English 4.0 KB
2023-02-23 00:00
Hinweis auf Konzernabschluss vom 01.01.2022 bis zum 31.12.2022
German 5.7 KB
2023-02-23 00:00
Hinweis auf Jahresfinanzbericht vom 01.01.2022 bis zum 31.12.2022
German 5.7 KB
2022-09-27 00:00
Ergänzung der Veröffentlichung vom 12.04.2022
German 2.2 KB
2022-08-17 09:49 English 4.0 KB
2022-08-17 00:00
Hinweis auf Halbjahresfinanzbericht vom 01.01.2022 bis zum 30.06.2022
German 5.7 KB
2022-05-10 00:00
Konzernabschluss zum Geschäftsjahr vom 01.01.2021 bis zum 31.12.2021
German 911.5 KB

Automate Your Workflow. Get a real-time feed of all STADA Arzneimittel AG filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for STADA Arzneimittel AG

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for STADA Arzneimittel AG via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.